Global Radioactive Diagnostic Drugs Supply, Demand and Key Producers, 2024-2030

February 2024 | 119 pages | ID: GEC8D3763C23EN
GlobalInfoResearch

Abstracts

The global Radioactive Diagnostic Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Radioactive Diagnostic Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radioactive Diagnostic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioactive Diagnostic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Radioactive Diagnostic Drugs total market, 2019-2030, (USD Million)

Global Radioactive Diagnostic Drugs total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Radioactive Diagnostic Drugs total market, key domestic companies and share, (USD Million)

Global Radioactive Diagnostic Drugs revenue by player and market share 2019-2024, (USD Million)

Global Radioactive Diagnostic Drugs total market by Type, CAGR, 2019-2030, (USD Million)

Global Radioactive Diagnostic Drugs total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Radioactive Diagnostic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Curium, Medi-Radiopharma, Jubilant Radiopharma, Telix, Mallinckrodt, Cardinal Health, Bayer AG, GE Healthcare and Mallinckrodt Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radioactive Diagnostic Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Radioactive Diagnostic Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Radioactive Diagnostic Drugs Market, Segmentation by Type

• Single Photon Drugs
• Positron Drugs
• Blood Perfusion Drugs
• Metabolizing Drugs
• Receptor Binding Drugs
• Others

Global Radioactive Diagnostic Drugs Market, Segmentation by Application

• Oncology
• Cardiology
• Neuroscience
• Thyroid
• Others

Companies Profiled:

• Curium
• Medi-Radiopharma
• Jubilant Radiopharma
• Telix
• Mallinckrodt
• Cardinal Health
• Bayer AG
• GE Healthcare
• Mallinckrodt Pharmaceuticals
• Bracco Group

Key Questions Answered

1. How big is the global Radioactive Diagnostic Drugs market?

2. What is the demand of the global Radioactive Diagnostic Drugs market?

3. What is the year over year growth of the global Radioactive Diagnostic Drugs market?

4. What is the total value of the global Radioactive Diagnostic Drugs market?

5. Who are the major players in the global Radioactive Diagnostic Drugs market?

Contents

1 SUPPLY SUMMARY

1.1 Radioactive Diagnostic Drugs Introduction
1.2 World Radioactive Diagnostic Drugs Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Radioactive Diagnostic Drugs Total Market by Region (by Headquarter Location)
  1.3.1 World Radioactive Diagnostic Drugs Market Size by Region (2019-2030), (by Headquarter Location)
  1.3.2 United States Radioactive Diagnostic Drugs Market Size (2019-2030)
  1.3.3 China Radioactive Diagnostic Drugs Market Size (2019-2030)
  1.3.4 Europe Radioactive Diagnostic Drugs Market Size (2019-2030)
  1.3.5 Japan Radioactive Diagnostic Drugs Market Size (2019-2030)
  1.3.6 South Korea Radioactive Diagnostic Drugs Market Size (2019-2030)
  1.3.7 ASEAN Radioactive Diagnostic Drugs Market Size (2019-2030)
  1.3.8 India Radioactive Diagnostic Drugs Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Radioactive Diagnostic Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Radioactive Diagnostic Drugs Major Market Trends

2 DEMAND SUMMARY

2.1 World Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.2 World Radioactive Diagnostic Drugs Consumption Value by Region
  2.2.1 World Radioactive Diagnostic Drugs Consumption Value by Region (2019-2024)
  2.2.2 World Radioactive Diagnostic Drugs Consumption Value Forecast by Region (2025-2030)
2.3 United States Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.4 China Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.5 Europe Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.6 Japan Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.7 South Korea Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.8 ASEAN Radioactive Diagnostic Drugs Consumption Value (2019-2030)
2.9 India Radioactive Diagnostic Drugs Consumption Value (2019-2030)

3 WORLD RADIOACTIVE DIAGNOSTIC DRUGS COMPANIES COMPETITIVE ANALYSIS

3.1 World Radioactive Diagnostic Drugs Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Radioactive Diagnostic Drugs Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Radioactive Diagnostic Drugs in 2023
  3.2.3 Global Concentration Ratios (CR8) for Radioactive Diagnostic Drugs in 2023
3.3 Radioactive Diagnostic Drugs Company Evaluation Quadrant
3.4 Radioactive Diagnostic Drugs Market: Overall Company Footprint Analysis
  3.4.1 Radioactive Diagnostic Drugs Market: Region Footprint
  3.4.2 Radioactive Diagnostic Drugs Market: Company Product Type Footprint
  3.4.3 Radioactive Diagnostic Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Radioactive Diagnostic Drugs Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Radioactive Diagnostic Drugs Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
  4.1.2 United States VS China: Radioactive Diagnostic Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Radioactive Diagnostic Drugs Consumption Value Comparison
  4.2.1 United States VS China: Radioactive Diagnostic Drugs Consumption Value Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Radioactive Diagnostic Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Radioactive Diagnostic Drugs Companies and Market Share, 2019-2024
  4.3.1 United States Based Radioactive Diagnostic Drugs Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Radioactive Diagnostic Drugs Revenue, (2019-2024)
4.4 China Based Companies Radioactive Diagnostic Drugs Revenue and Market Share, 2019-2024
  4.4.1 China Based Radioactive Diagnostic Drugs Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Radioactive Diagnostic Drugs Revenue, (2019-2024)
4.5 Rest of World Based Radioactive Diagnostic Drugs Companies and Market Share, 2019-2024
  4.5.1 Rest of World Based Radioactive Diagnostic Drugs Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Radioactive Diagnostic Drugs Revenue, (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Radioactive Diagnostic Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Single Photon Drugs
  5.2.2 Positron Drugs
  5.2.3 Blood Perfusion Drugs
  5.2.4 Metabolizing Drugs
  5.2.5 Receptor Binding Drugs
  5.2.6 Others
5.3 Market Segment by Type
  5.3.1 World Radioactive Diagnostic Drugs Market Size by Type (2019-2024)
  5.3.2 World Radioactive Diagnostic Drugs Market Size by Type (2025-2030)
  5.3.3 World Radioactive Diagnostic Drugs Market Size Market Share by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Radioactive Diagnostic Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Oncology
  6.2.2 Cardiology
  6.2.3 Neuroscience
  6.2.4 Thyroid
  6.2.5 Thyroid
6.3 Market Segment by Application
  6.3.1 World Radioactive Diagnostic Drugs Market Size by Application (2019-2024)
  6.3.2 World Radioactive Diagnostic Drugs Market Size by Application (2025-2030)
  6.3.3 World Radioactive Diagnostic Drugs Market Size by Application (2019-2030)

7 COMPANY PROFILES

7.1 Curium
  7.1.1 Curium Details
  7.1.2 Curium Major Business
  7.1.3 Curium Radioactive Diagnostic Drugs Product and Services
  7.1.4 Curium Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.1.5 Curium Recent Developments/Updates
  7.1.6 Curium Competitive Strengths & Weaknesses
7.2 Medi-Radiopharma
  7.2.1 Medi-Radiopharma Details
  7.2.2 Medi-Radiopharma Major Business
  7.2.3 Medi-Radiopharma Radioactive Diagnostic Drugs Product and Services
  7.2.4 Medi-Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.2.5 Medi-Radiopharma Recent Developments/Updates
  7.2.6 Medi-Radiopharma Competitive Strengths & Weaknesses
7.3 Jubilant Radiopharma
  7.3.1 Jubilant Radiopharma Details
  7.3.2 Jubilant Radiopharma Major Business
  7.3.3 Jubilant Radiopharma Radioactive Diagnostic Drugs Product and Services
  7.3.4 Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.3.5 Jubilant Radiopharma Recent Developments/Updates
  7.3.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
7.4 Telix
  7.4.1 Telix Details
  7.4.2 Telix Major Business
  7.4.3 Telix Radioactive Diagnostic Drugs Product and Services
  7.4.4 Telix Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.4.5 Telix Recent Developments/Updates
  7.4.6 Telix Competitive Strengths & Weaknesses
7.5 Mallinckrodt
  7.5.1 Mallinckrodt Details
  7.5.2 Mallinckrodt Major Business
  7.5.3 Mallinckrodt Radioactive Diagnostic Drugs Product and Services
  7.5.4 Mallinckrodt Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.5.5 Mallinckrodt Recent Developments/Updates
  7.5.6 Mallinckrodt Competitive Strengths & Weaknesses
7.6 Cardinal Health
  7.6.1 Cardinal Health Details
  7.6.2 Cardinal Health Major Business
  7.6.3 Cardinal Health Radioactive Diagnostic Drugs Product and Services
  7.6.4 Cardinal Health Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.6.5 Cardinal Health Recent Developments/Updates
  7.6.6 Cardinal Health Competitive Strengths & Weaknesses
7.7 Bayer AG
  7.7.1 Bayer AG Details
  7.7.2 Bayer AG Major Business
  7.7.3 Bayer AG Radioactive Diagnostic Drugs Product and Services
  7.7.4 Bayer AG Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.7.5 Bayer AG Recent Developments/Updates
  7.7.6 Bayer AG Competitive Strengths & Weaknesses
7.8 GE Healthcare
  7.8.1 GE Healthcare Details
  7.8.2 GE Healthcare Major Business
  7.8.3 GE Healthcare Radioactive Diagnostic Drugs Product and Services
  7.8.4 GE Healthcare Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.8.5 GE Healthcare Recent Developments/Updates
  7.8.6 GE Healthcare Competitive Strengths & Weaknesses
7.9 Mallinckrodt Pharmaceuticals
  7.9.1 Mallinckrodt Pharmaceuticals Details
  7.9.2 Mallinckrodt Pharmaceuticals Major Business
  7.9.3 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product and Services
  7.9.4 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.9.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
  7.9.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Bracco Group
  7.10.1 Bracco Group Details
  7.10.2 Bracco Group Major Business
  7.10.3 Bracco Group Radioactive Diagnostic Drugs Product and Services
  7.10.4 Bracco Group Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
  7.10.5 Bracco Group Recent Developments/Updates
  7.10.6 Bracco Group Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Radioactive Diagnostic Drugs Industry Chain
8.2 Radioactive Diagnostic Drugs Upstream Analysis
8.3 Radioactive Diagnostic Drugs Midstream Analysis
8.4 Radioactive Diagnostic Drugs Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES
.
Table 1. World Radioactive Diagnostic Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Radioactive Diagnostic Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Radioactive Diagnostic Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Radioactive Diagnostic Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Radioactive Diagnostic Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radioactive Diagnostic Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Radioactive Diagnostic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Radioactive Diagnostic Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Radioactive Diagnostic Drugs Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Radioactive Diagnostic Drugs Players in 2023
Table 12. World Radioactive Diagnostic Drugs Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Radioactive Diagnostic Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Radioactive Diagnostic Drugs Player
Table 15. Radioactive Diagnostic Drugs Market: Company Product Type Footprint
Table 16. Radioactive Diagnostic Drugs Market: Company Product Application Footprint
Table 17. Radioactive Diagnostic Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Radioactive Diagnostic Drugs Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Radioactive Diagnostic Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Radioactive Diagnostic Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radioactive Diagnostic Drugs Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Radioactive Diagnostic Drugs Revenue Market Share (2019-2024)
Table 23. China Based Radioactive Diagnostic Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radioactive Diagnostic Drugs Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Radioactive Diagnostic Drugs Revenue Market Share (2019-2024)
Table 26. Rest of World Based Radioactive Diagnostic Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Radioactive Diagnostic Drugs Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Radioactive Diagnostic Drugs Revenue Market Share (2019-2024)
Table 29. World Radioactive Diagnostic Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Radioactive Diagnostic Drugs Market Size by Type (2019-2024) & (USD Million)
Table 31. World Radioactive Diagnostic Drugs Market Size by Type (2025-2030) & (USD Million)
Table 32. World Radioactive Diagnostic Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Radioactive Diagnostic Drugs Market Size by Application (2019-2024) & (USD Million)
Table 34. World Radioactive Diagnostic Drugs Market Size by Application (2025-2030) & (USD Million)
Table 35. Curium Basic Information, Area Served and Competitors
Table 36. Curium Major Business
Table 37. Curium Radioactive Diagnostic Drugs Product and Services
Table 38. Curium Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Curium Recent Developments/Updates
Table 40. Curium Competitive Strengths & Weaknesses
Table 41. Medi-Radiopharma Basic Information, Area Served and Competitors
Table 42. Medi-Radiopharma Major Business
Table 43. Medi-Radiopharma Radioactive Diagnostic Drugs Product and Services
Table 44. Medi-Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Medi-Radiopharma Recent Developments/Updates
Table 46. Medi-Radiopharma Competitive Strengths & Weaknesses
Table 47. Jubilant Radiopharma Basic Information, Area Served and Competitors
Table 48. Jubilant Radiopharma Major Business
Table 49. Jubilant Radiopharma Radioactive Diagnostic Drugs Product and Services
Table 50. Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Jubilant Radiopharma Recent Developments/Updates
Table 52. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 53. Telix Basic Information, Area Served and Competitors
Table 54. Telix Major Business
Table 55. Telix Radioactive Diagnostic Drugs Product and Services
Table 56. Telix Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Telix Recent Developments/Updates
Table 58. Telix Competitive Strengths & Weaknesses
Table 59. Mallinckrodt Basic Information, Area Served and Competitors
Table 60. Mallinckrodt Major Business
Table 61. Mallinckrodt Radioactive Diagnostic Drugs Product and Services
Table 62. Mallinckrodt Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Mallinckrodt Recent Developments/Updates
Table 64. Mallinckrodt Competitive Strengths & Weaknesses
Table 65. Cardinal Health Basic Information, Area Served and Competitors
Table 66. Cardinal Health Major Business
Table 67. Cardinal Health Radioactive Diagnostic Drugs Product and Services
Table 68. Cardinal Health Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Cardinal Health Recent Developments/Updates
Table 70. Cardinal Health Competitive Strengths & Weaknesses
Table 71. Bayer AG Basic Information, Area Served and Competitors
Table 72. Bayer AG Major Business
Table 73. Bayer AG Radioactive Diagnostic Drugs Product and Services
Table 74. Bayer AG Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Bayer AG Recent Developments/Updates
Table 76. Bayer AG Competitive Strengths & Weaknesses
Table 77. GE Healthcare Basic Information, Area Served and Competitors
Table 78. GE Healthcare Major Business
Table 79. GE Healthcare Radioactive Diagnostic Drugs Product and Services
Table 80. GE Healthcare Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. GE Healthcare Recent Developments/Updates
Table 82. GE Healthcare Competitive Strengths & Weaknesses
Table 83. Mallinckrodt Pharmaceuticals Basic Information, Area Served and Competitors
Table 84. Mallinckrodt Pharmaceuticals Major Business
Table 85. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product and Services
Table 86. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 88. Bracco Group Basic Information, Area Served and Competitors
Table 89. Bracco Group Major Business
Table 90. Bracco Group Radioactive Diagnostic Drugs Product and Services
Table 91. Bracco Group Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Radioactive Diagnostic Drugs Upstream (Raw Materials)
Table 93. Radioactive Diagnostic Drugs Typical Customers

LIST OF FIGURE
.
Figure 1. Radioactive Diagnostic Drugs Picture
Figure 2. World Radioactive Diagnostic Drugs Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Radioactive Diagnostic Drugs Total Market Size (2019-2030) & (USD Million)
Figure 4. World Radioactive Diagnostic Drugs Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Radioactive Diagnostic Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Radioactive Diagnostic Drugs Revenue (2019-2030) & (USD Million)
Figure 13. Radioactive Diagnostic Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 16. World Radioactive Diagnostic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 18. China Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. India Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Radioactive Diagnostic Drugs by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radioactive Diagnostic Drugs Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radioactive Diagnostic Drugs Markets in 2023
Figure 27. United States VS China: Radioactive Diagnostic Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Radioactive Diagnostic Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Radioactive Diagnostic Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Radioactive Diagnostic Drugs Market Size Market Share by Type in 2023
Figure 31. Single Photon Drugs
Figure 32. Positron Drugs
Figure 33. Blood Perfusion Drugs
Figure 34. Metabolizing Drugs
Figure 35. Receptor Binding Drugs
Figure 36. Others
Figure 37. World Radioactive Diagnostic Drugs Market Size Market Share by Type (2019-2030)
Figure 38. World Radioactive Diagnostic Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 39. World Radioactive Diagnostic Drugs Market Size Market Share by Application in 2023
Figure 40. Oncology
Figure 41. Cardiology
Figure 42. Neuroscience
Figure 43. Thyroid
Figure 44. Others
Figure 45. Radioactive Diagnostic Drugs Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source